Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62Llo memory-effector cell pool during latent murine cytomegalovirus infection of the lungs

Journal of Virology

Volumn 74, Issue 24, 2000, Pages 11495-11503

  Holtappels, R ^a   Pahl Seibert, M F ^a   Thomas, D ^a   Reddehase, M J ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CELL MARKER;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVATION; CLEARANCE; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; HELPER CELL; IMMEDIATE EARLY GENE; INTERSTITIAL PNEUMONIA; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SUPPRESSOR CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC MEMORY; LUNG; MICE; MICE, INBRED BALB C; VIRUS LATENCY;

EID: 0034468083     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.24.11495-11503.2000     Document Type: Article

References (60)

1. Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigenpresenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells
2. The major immediate-early gene ie3 of mouse cytomegalovirus is essential for viral growth
3. Memory T lymphocytes
4. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes
5. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"?
6. Lungs are a major organ site of cytomegalovirus latency and recurrence
7. Recognition of human cytomegalovirus (HCMV) gene products by HCMV-specific cytotoxic T cells
8. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses
9. Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cyto megalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins
10. + T cells in primary and secondary influenza pneumonia
11. + T cells
12. Virologic and pathogenetic aspects of cytomegalovirus infection
13. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
14. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans
15. Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist
16. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus
17. Control of murine cytomegalovirus in the lungs: Relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates
18. The putative natural killer decoy early gene mO4 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells
19. d- restricted antigenic peptide encoded by murine cytomegalovirus early gene M84
20. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface
21. Principles of cytomegalovirus antigen presentation in vitro and in vivo
22. The role of T-lymphocyte subsets in the control of cytomegalovirus infection
23. Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes
24. On the role of antigen in maintaining cytotoxic T-cell memory
25. On T cell memory: Arguments for antigen dependence Immunol
26. Focal transcriptional activity of murine cytomegalovirus during latency in the lungs
27. Patchwork pattern of transcriptional reactivation in the lungs indicates sequential checkpoints in the transition from murine cytomegalovirus latency to recurrence
28. Latency versus persistence or intermittent recurrences: Evidence for a latent state of murine cytomegalovirus in the lungs
29. Cytotoxic T cell memory without antigen
30. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes
31. Structural organization, expression, and functional characterization of the murine cytomegalovirus immediate-early gene 3
32. Quantification of antigen-specific CD8+ T cells using an ELISPOT assay
33. Regulation of adhesion molecule expression by CD8 T cells in vivo. II. Expression of L-selectin (CD62L) by memory cytolytic T cells responding to minor histocompatibility antigens
34. In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83)
35. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65)
36. Persistence of memory CD8 T cells in MHC class I-deficient mice
37. Murine model of interstitial cytomegalovirus pneumonia in syngeneic bone marrow transplantation: Persistence of protective pulmonary. CD8-T-cell infiltrates after clearance of acute infection
38. Reconstitution of CD8 T cells is essential for the prevention of multiple-organ cytomegalovirus histopathology after bone marrow transplantation
39. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection
40. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus
41. The immunogenicity of human and murine cytomegaloviruses
42. The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease
43. Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors
44. Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection
45. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity
46. A pentapeptide as minimal antigenic determinant for MHC class I-restricted lymphocytes
47. Interstitial murine cytomegalovirus pneumonia after irradiation: Characterization of cells that limit viral replication during established infection of the lungs
48. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
49. Cytotoxic toxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
50. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones
51. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide
52. Preemptive CD8-T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genome, and reduces the risk of virus recurrence
53. Detection of individual mouse splenic T cells producing IFN-γ and IL-5 using the enzyme-linked immunospot (ELISPOT) assay
54. The selectins: Vascular adhesion molecules
55. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
56. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: An immunodominant region which induces nonreciprocal CTL cross-reactivity
57. Cytomegaloviruses use multiple mechanisms to elude the host immune response
58. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, speci ficity, and T-cell receptor usage of pp65-specific CTL
59. The luminal part of the murine cytomegalovirus glycoprotein gp40 catalyzes the retention of MHC class I molecules